The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Lumbosacral Radicular Pain Market In 2026 And How Much Will It Reach By 2030?
The lumbosacral radicular pain market size has demonstrated robust growth in recent years. It is projected to expand from $0.97 billion in 2025 to $1.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. This market’s historical growth can be linked to factors such as an aging population, spinal degenerative disorders, opioid-based pain management, the presence of hospital pain clinics, and the volume of orthopedic surgery procedures.
The lumbosacral radicular pain market size is projected to experience robust expansion in the coming years. It is set to reach $1.28 billion in 2030, showing a compound annual growth rate (CAGR) of 5.7%. The anticipated growth within the forecast period can be attributed to factors such as the adoption of non-opioid pain therapies, an increase in outpatient pain procedures, the availability of digital pain monitoring tools, advancements in minimally invasive spine technologies, and the expansion of rehabilitation programs. Major trends influencing this period include the rising utilization of multimodal pain management strategies, the growth of interventional spine procedures, an increased demand for non-opioid therapies, the broadening of rehabilitation-based care, and the integration of minimally invasive pain treatments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp
Which Strategic Drivers Are Supporting The Lumbosacral Radicular Pain Market Development?
The growing occurrence of degenerative spinal conditions is projected to boost the lumbosacral radicular pain market’s expansion in the future. These conditions encompass various disorders resulting from the progressive deterioration of the spine over time. This increase stems from demographic shifts towards older populations and lifestyle choices that elevate the likelihood of spinal degradation and nerve impingement, consequently driving up the need for diagnostic and therapeutic interventions. Lumbosacral radicular pain serves as an indicator for underlying degenerative spinal issues by signaling nerve root irritation or compression, thereby informing clinical assessment and patient care. As an illustration, the University of Sydney, an Australia-based public university, reported in May 2023 that global back discomfort is expected to affect over 800 million individuals by 2050. Consequently, the rising incidence of degenerative spinal conditions is a key driver for the expansion of the lumbosacral radicular pain market.
How Is The Lumbosacral Radicular Pain Market Distributed Across Key Segments?
The lumbosacral radicular pain market covered in this report is segmented –
1) By Treatment Type: Pharmacological Treatment, Non-Pharmacological Treatment, Interventional Procedures
2) By Route Of Administration: Oral, Topical, Injectable, Implantable
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End User: Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings
Subsegments:
1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Anticonvulsants, Antidepressants, Muscle Relaxants, Corticosteroids
2) By Non-Pharmacological Treatment: Physical Therapy, Exercise And Rehabilitation Programs, Chiropractic Care, Acupuncture, Cognitive Behavioral Therapy, Heat And Cold Therapy
3) By Interventional Procedures: Epidural Steroid Injections, Radiofrequency Ablation, Nerve Root Blocks, Spinal Cord Stimulation, Minimally Invasive Decompression, Intrathecal Drug Delivery Systems
Which Companies Are Engaged In The Lumbosacral Radicular Pain Market Environment?
Major companies operating in the lumbosacral radicular pain market are Medtronic plc, Boston Scientific Corporation, Nevro Corp., SPR Therapeutics, Saluda Medical Pty Ltd., Nalu Medical Inc., Abbott Neuromodulation, Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., B. Braun Melsungen AG, Teleflex Incorporated, Merit Medical Systems Inc., Avanos Medical Inc., Halyard Health Inc., Terumo Corporation, Baxter International Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Pfizer CentreOne, Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Lupin Limited, Zydus Lifesciences Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Perrigo Company plc
Access The Complete Lumbosacral Radicular Pain Market Report:
https://www.thebusinessresearchcompany.com/report/lumbosacral-radicular-pain-global-market-report
Which Region Stands As The Largest Contributor To The Lumbosacral Radicular Pain Market?
North America was the largest region in the lumbosacral radicular pain market in 2025. The regions covered in the lumbosacral radicular pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Lumbosacral Radicular Pain Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24591&type=smp
Browse Through More Reports Similar to the Global Lumbosacral Radicular Pain Market 2026, By The Business Research Company
Joint Pain Injections Market Report 2026
https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report
Neuropathic Pain Market Report 2026
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
Chronic Pain Market Report 2026
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model